Levy V, Srivastava T, Gautam R, Swami S, et al. Toxicity, progression-free survival, and quality of life of patients treated with zanubrutinib versus ibrutinib: a Q-TWiST analysis from the ALPINE study in relapsed or refractory chronic lymphocytic leukemia. Leuk Lymphoma 2025 May 23:1-9. doi: 10.1080/10428194.2025.2506501.
PMID: 40407269